Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Siim Pauklin on the award of his CRUK Career Development Fellowship entitled ‘Molecular Mechanisms Regulating Cancer Stem Cell Formation and Maintenance in Pancreatic Cancer’.

Siim has been awarded £1.5 million to investigate the molecular machineries that provide stem cell-like characteristics to cancer stem cells in pancreatic ductal adenocarcinomas. This type of cancer is one of the most lethal human malignancies and so it is very important to gain some insight into their mechanism of formation. Hopefully this research will uncover novel signal transduction pathways which could provide new targets for diagnosis and treatment. This is expected to be accomplished by utilising state-of-the-art cell culture methods with genome-wide techniques, proteomics, in vitro mechanistic studies and in vivo tumorigenesis experiments.

Under the mentorship of Professor Udo Oppermann, Siim, aims to establish himself as a group leader and independent researcher in stem cell and cancer research.  The Botnar Research Centre will support him with the resources and research equipment required to run his research programme for the duration of the Fellowship and beyond.

Speaking of his award and future research, Siim said: “The CRUK Career Development Fellowship will provide outstanding support to me for establishing my research group. I am very glad. It is my hope that by combining stem cell biology and cancer research, we will uncover crucial aspects in cancer stem cell formation from a new angle. This insight will be essential for developing more efficient cancer therapeutics and bring us closer to conquering this deadly disease.”

The grant started in January 2018 and runs for six years. 

Similar stories

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).